Here, the proportion of CD14+ monocyte cells and the expression level of CXCR3 of Tregs in severe COVID-19 patients supported that the ligand-receptor pair of PF4_CXCR3 promotes the activation of HLA_DR+ Tregs in severe COVID-19 patients. The gene discussed is CXCR3; the disease is COVID-19.